Advances in contraception

Obstetrics and Gynecology Clinics of North America

Volumn 27, Issue 3, 2000, Pages 597-610

  Davis, Ann J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

BREAST CANCER; CANCER RISK; CONTRACEPTION; HUMAN; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; UNITED STATES;

EID: 0033840786     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70158-3     Document Type: Article

References (26)

1. Combination oral contraceptive use and endometrial cancer
2. The reduction in risk of ovarian cancer associated with oral contraceptive use
3. Family planning, sexually transmitted diseases and contraceptive choice: A literature update
4. Breast cancer and hormonal contraceptives: Collaborative re-analysis of individual data on 53,297 women with breast cancer and 100,239 without breast cancer from 54 epidemiological studies
5. A prospective comparison of bone density in adolescent girls on depo-medroxyprogesterone acetate, levonorgestrel, or oral contraceptives
6. Recovery of bone density in women who stop using medroxyprogesterone acetate
7. The intrauterine contraceptive device: An often forgotten and maligned method of contraception
8. Intrauterine devices and pelvic inflammatory disease: An international perspective
9. Trends in OC development and utilization
10. Helping teenagers postpone sexual involvement
11. The impact of the postponing sexual involvement curriculum among youths in California
12. The increased risk of venous thromboembolism and the use of third generation progestins: Role of bias in observation research
13. No evidence to support IUD and embryo destruction
14. Return of fertility after use of the injectable contraceptive Depo-Provera: Up-dated data analysis
15. Measuring compliance among oral contraceptive users
16. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings: Use effectiveness. An international comparative trial
17. Comparative risks and costs of male and female sterilization
18. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception
19. Oral contraceptives and venous thromboembolism: Should epidemiological associations drive clinical decision making?
20. Intrauterine device termination rates and the menstrual cycle day of insertion